Multi-omics profiling identifies a CXCL9-PD-1 + CD8 + T cell axis for prediction of checkpoint inhibitor pneumonitis
Year: 2026
Type: article
Study design: Observational Study
Abstract: Background Checkpoint inhibitor pneumonitis (CIP) is a life-threatening complication of immune checkpoint inhibitors (ICI). We aimed to identify predictive biomarkers associated with symptomatic CIP (sCIP) and unravel the underlying pathogenesis. Methods We integrated CyTOF, proteomics, single-cell RNA and V(D)J sequencing, single-cell secretomics, and spatial transcriptomics. These techniques were used to profile peripheral blood, bronchoalveolar lavage fluid, and lung tissue samples from two prospective multi-center cohorts of NSCLC patients receiving ICI combination treatments. Results Elevated serum CXCL9 levels combined with high frequencies of peripheral PD-1 + CD8 + T cells after induction ICI were associated with subsequent sCIP (AUC=0.954) and inferior overall survival (HR=7.19, p=0.004). Mechanistically, PD-1 + CD8 + T cells displayed a type 1 effector profile characterized by IFN-γ and MIP-1β secretion. CXCL9/CXCR3 signaling was associated with recruitment of these cells to inflamed lung tissue. Conclusions The CXCL9-PD-1 + CD8 + T cell axis is associated with CIP pathogenesis. This mechanism supports a potential blood-based biomarker model for CIP risk stratification and identifies a promising preventive therapeutic target to optimize clinical management.
Source: European Respiratory Journal
Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, National Cancer Center, Cancer Hospital of Chinese Academy of Medical Sciences, China-Japan Friendship Hospital, Ministry of Education, Cancer Hospital of Huanxing Chaoyang District Beijing, Shanxi Medical University, Shanxi Provincial Cancer Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W7236737739
